This Article Full Text Full Text (PDF) All Versions of this Article: 120/12/1048    most recent CIRCULATIONAHA.108.842328v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by McDermott, M. M. Articles by Criqui, M. H. PubMed PubMed Citation Articles by McDermott, M. M. Articles by Criqui, M. H. Related Collections Pathophysiology Risk Factors Peripheral vascular disease Other imaging Epidemiology Related Article

(Circulation. 2009;120:1048-1055.)
© 2009 American Heart Association, Inc.

Epidemiology and Prevention

Pathophysiological Changes in Calf Muscle Predict Mobility Loss at 2-Year Follow-Up in Men and Women With Peripheral Arterial Disease

Mary McGrae McDermott, MD; Luigi Ferrucci, MD, PhD; Jack Guralnik, MD, PhD; Lu Tian, ScD; Kiang Liu, PhD; Frederick Hoff, MD; Yihua Liao, MS; Michael H. Criqui, MD, MPH

From the Feinberg School of Medicine, Northwestern University, Chicago, Ill (M.M.M., K.L., F.H., Y.L.); National Institute on Aging, Bethesda, Md (L.F., J.G.); Stanford University, Stanford, Calif (L.T.); and University of California at San Diego (M.H.C.).

Correspondence to Dr Mary M. McDermott, 750 N Lake Shore Dr, 10th Floor, Chicago, IL 60611. E-mail mdm608{at}northwestern.edu

Received December 16, 2008; accepted June 25, 2009.

Background— Associations of pathophysiological calf muscle characteristics with functional decline in people with lower extremity peripheral arterial disease are unknown.

Methods and Results— Three hundred seventy participants with peripheral arterial disease underwent baseline measurement of calf muscle area, density, and percent fat with the use of computed tomography. Participants were followed up annually for 2 years. The outcome of mobility loss was defined as becoming unable to walk 1/4 mile or walk up and down 1 flight of stairs without assistance among those without baseline mobility limitations. Additional outcomes were 20% decline in 6-minute walk distance and becoming unable to walk for 6 minutes continuously among participants who walked continuously for 6 minutes at baseline. With adjustment for age, sex, race, body mass index, the ankle-brachial index, smoking, physical activity, relevant medications, and comorbidities, lower calf muscle density (P for trend <0.001) and lower calf muscle area (P for trend=0.039) were each associated with increased mobility loss rates. Compared with participants in the highest baseline tertiles, participants in the lowest tertile of calf muscle percent fat had a hazard ratio of 0.18 for incident mobility loss (95% confidence interval, 0.06 to 0.55; P=0.003), and participants in the lowest tertile of muscle density had a 3.50 hazard ratio for incident mobility loss (95% confidence interval, 1.28 to 9.57; P=0.015). No significant associations of calf muscle characteristics with 6-minute walk outcomes were observed.

Conclusions— Our findings suggest that interventions to prevent mobility loss in peripheral arterial disease should focus on reversing pathophysiological findings in calf muscle.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2009 120: 1021-1023. [Extract] [Full Text]